BHI Board of Directors

TEST Peter Briskman is a seasoned executive and real estate leader with a distinguished career specializing in life sciences. As the Executive Managing Director and Lead for the Mid-Atlantic Life Sciences Practice at Jones Lang LaSalle (JLL), Peter drives strategic initiatives to meet the unique needs of biotech, pharmaceutical, and medical device companies. With over two decades of expertise in commercial real estate, he has been instrumental in fostering growth and innovation within the Mid-Atlantic region’s life sciences sector. Peter’s leadership encompasses advisory services, market analysis, and facility optimization, enabling clients to secure cutting-edge laboratories, manufacturing sites, and research hubs. Under his guidance, JLL has strengthened its position as a key partner to organizations navigating complex real estate challenges in a competitive industry. Renowned for his deep understanding of the life sciences ecosystem, Peter collaborates with stakeholders across academia, private industry, and government to advance the region as a global hub for innovation. A strong advocate for economic development and sustainability, he combines visionary planning with practical execution. Peter holds a degree in business and real estate and regularly contributes insights at industry conferences. His dedication to fostering life sciences excellence continues to shape the Mid-Atlantic’s role in advancing healthcare

Donna Edmonds is the visionary Founder and CEO of Brainbox Solutions, a groundbreaking company at the forefront of artificial intelligence and cognitive computing. With a passion for harnessing technology to solve complex problems, Donna has built Brainbox Solutions into a leader in developing AI-driven tools that enhance decision-making, optimize operations, and drive innovation across industries. Donna’s career spans over two decades in technology and business leadership. Prior to founding Brainbox Solutions, she held executive roles in prominent tech firms, where she led large-scale digital transformation initiatives and spearheaded the development of cutting-edge software solutions. Her ability to identify emerging trends and translate them into actionable strategies has earned her a reputation as a trailblazer in the AI space. Under Donna’s leadership, Brainbox Solutions has launched numerous successful products, including platforms that empower businesses to unlock insights from data and improve efficiency through automation. A champion of diversity and inclusion, she is committed to fostering a workplace culture that nurtures creativity and collaboration. Donna holds degrees in computer science and business administration and is a sought-after speaker at technology conferences worldwide. Her innovative mindset and dedication to pushing the boundaries of AI continue to shape the future of intelligent technology solutions.

David Lemus serves as the Chief Financial Officer and Chief Operating Officer at miRecule, a pioneering biotechnology company advancing RNA-based therapeutics to address critical unmet medical needs. With over 25 years of experience in financial and operational leadership within the life sciences sector, David is instrumental in steering miRecule’s strategic growth and operational excellence. Prior to joining miRecule, David held senior leadership roles at several prominent biopharmaceutical and healthcare companies. He has a proven track record of securing financing, driving business development initiatives, and optimizing operations to scale innovation and deliver transformative therapies. His expertise spans financial strategy, mergers and acquisitions, fundraising, and global market expansion. At miRecule, David oversees financial planning, investor relations, and day-to-day operations, ensuring alignment between the company’s scientific advancements and business objectives. His leadership has been pivotal in miRecule’s progression from early-stage research to clinical development. David is recognized for his ability to integrate financial acumen with a deep understanding of the biotech landscape, making him a trusted partner to both internal teams and external stakeholders. He holds degrees in finance and business management and actively participates in industry forums, sharing insights to advance the life sciences field.

Charles Morton is a seasoned attorney and partner at Venable LLP, where he specializes in corporate law, mergers and acquisitions, and venture capital. With decades of experience advising companies, investors, and entrepreneurs, Charles has become a trusted legal advisor to some of the most dynamic businesses in the technology, life sciences, and healthcare sectors. At Venable, Charles leads complex transactions, guiding clients through financings, strategic partnerships, and exit strategies. His deep understanding of the legal and business intricacies of growing enterprises makes him a go-to resource for startups and established companies alike. Known for his pragmatic approach and ability to simplify complex issues, he has helped clients secure successful outcomes in high-stakes negotiations and deals. Charles is also deeply involved in the entrepreneurial ecosystem, often mentoring emerging companies and working with investors to foster innovation and growth. He is a sought-after speaker at industry events, sharing insights on venture capital trends, corporate governance, and emerging markets. A graduate of top-tier institutions in law and business, Charles is recognized by peers and clients for his commitment to excellence and results-driven counsel. His work continues to shape the success of businesses navigating the fast-paced, competitive landscapes of today’s economy.

   

   

   

   

     

Prinicipal Deliotte Consulting, LLP